Portal hypertension (PHT) is characterized by splanchnic hyperemia due to a reduction in mesenteric vascular resistance. We hypothesized that alterations in the activity of a guaninenucleotide regulatory protein (G-protein) might be partially responsible for the marked circulatory disturbances observed in PHT. We, therefore, determined alterations in adenylyl cyclase/cAMP system in prehepatic portal hypertensive rabbits and correlated these changes to the activity of a G-protein.
Introduction
Chronic portal hypertension (PHT)' results in both increased portal pressure and reduced splanchnic vascular resistance, leading to marked splanchnic hyperemia ( 1) . Similar changes have been reported in several animal models of PHT (1) . Prehepatic PHT due to portal venous obstruction is associated with a fall in portal venous collateral resistance as the portal-guanyl-5'-y-(6-imino)-diphosphate; NL, animals operated on the day of the experiment; PGI, prostacyclin; PHT, portal hypertension; PV, portal vein; SMA, superior mesenteric artery; TA, thoracic aorta; TBS, Tris-buffered saline.
collateral shunt develops (2) (3) (4) . Several studies indicate that the increase in splanchnic arterial blood flow could maintain elevations in portal pressure despite the development of portosystemic collaterals, which shunt up to 90% of the total portal blood flow (2) (3) (4) . This increase in portal inflow is associated with a reduction in both peripheral vascular resistance and systemic arterial pressure, resulting in an increase in cardiac output (2) . In addition, there is a decreased splanchnic and systemic vascular responsiveness to vasoconstrictor stimuli (3) (4) (5) . However, both the mechanism of the hemodynamic changes and its relationship to PHT is not well understood.
The etiology of the increased mesenteric blood flow includes a decreased responsiveness to and/or production of endogenous vasoconstrictors (5, 6) or an excess of vasodilatory substances (3, 4, 7, 8) . The suggested major vasoactive substances in PHT are angiotensin-II, vasopressin, a-adrenergics, f3-adrenergics, glucagon, nitric oxide, and prostacyclin (PGI2) (3, 7, 9, 10) . PHT is associated with an increase in serum prostacyclin, nitric oxide, catecholamine, and glucagon concentrations (3, 4, 7, 9-1 1 ). Chronically elevated levels ofthese hormones may lead to an impairment of both neural (a/,8-adrenergic) and humoral (angiotensin-II and vasopressin) control of splanchnic vascular resistance. Recently, it has been suggested that the pressor hyporesponsiveness to norepinephrine, vasopressin, and angiotensin-I in the superior mesenteric artery and thoracic aorta of PHT rats may be partially related to the ability ofexogenously applied dilators (e.g., PGI2, glucagon, and nitric oxide) to interfere with the actions of exogenously applied vasoconstrictors ( 1) . These reports have led many investigators to suggest that loss of vascular responsiveness to these vasoconstrictive hormones in the portal-mesenteric vein and superior mesenteric artery may contribute both to the increase in portal pressure and the intestinal vasodilation of PHT (3, 4, 6, 1 1 ). In alcoholic cirrhosis, portal venous pressure correlates significantly with the activity ofthe sympathetic nervous system ( 12) . This correlation implies a direct regulatory influence of the sympathetic nervous system on splanchnic hemodynamics and portal pressure.
Guanine-nucleotide regulatory proteins (G-proteins) are key components in cellular signaling processes. G-proteins are a family of cell membrane proteins that link cell surface receptors to intracellular second messenger systems; e.g., adenylyl cyclase (AC) and phospholipase C. Generation of cAMP by AC is under dual control from receptor-coupled G proteins, namely Gs proteins, which serve to couple stimulatory receptors to AC, and Gi proteins, which serve to couple inhibitory receptors to AC ( 13) . Previous studies have reported a downregulation of f3-adrenoreceptors in cirrhotic patients (14) .
Moreover, cAMP responsiveness to f3-adrenoreceptor stimulation is diminished in lymphocytes of cirrhotic patients ( 14) . This may indicate sympathetic abnormalities in PHT and could reflect a down-regulation of adrenergic receptors. This is suggested by work showing resistance to the vasoconstrictive effect ofexogenous norepinephrine in the intestinal and peripheral vasculature of experimental animals (11) and in man ( 12) . Moreover, the catecholamine-induced relaxation (after a-adrenoceptor blockade) of portal and mesenteric veins from portal hypertensive rats is decreased in PHT (15, 16, 17) . Some investigators suggest that in the prehepatic PHT rat model the most important functional vasoconstrictor defect is loss in adrenergic vascular tone within the intestinal microcirculation ( 11). Diminished splanchnic vascular responsiveness to norepinephrine may involve altered function ofthe receptor and/or postreceptor processes that ultimately result in contraction.
Therefore, the aim of the present study was to investigate the responsiveness of PHT animals to sympathetic stimulation by determination of cAMP levels since it has been suggested that the AC/cAMP system is one of the major biochemical mechanisms that participates in the regulation of arterial tone and reactivity ( 18) . Furthermore, we have determined the stimulatory effects ofguanine nucleotides and the diterpene derivative, forskolin, on AC activity and correlated these changes to alterations in the amount and functional activity of guanine nucleotide regulatory proteins (Gs/Gi) using both pertussis toxin-and cholera toxin-sensitive ribosylation of Gia and Gs/ substrates and specific antibodies for Gsa and Gia.
Methods
Materials. ATP, GTP, cAMP, creatinine phosphate, creatine phospho- (30 Ci/mmol) , and '25I-rProtein A (2,000 Ci/mmol) were purchased from New England Nuclear (Boston, MA). Antisera against Gsa (RM/1 ), Gial /Gia2 (AS/7), and Gia3/Goa (EC/2) were purchased from New England Nuclear. Nitrocellulose membranes (HYBOND-C) were obtained from Amersham (Arlington Heights, IL). All other chemicals were of the highest purity commercially available.
Animals. Adult male New Zealand white rabbits (2.7-3.3 kg) were used for all studies. Rabbits were housed in a controlled environment and allowed free access to a moderate sodium diet (Purina Rabbit Chow, sodium 0.33%, Ralston Purina Co., St. Louis, MO) until the time of study. All studies were approved by the Johns Hopkins University Animal Care and Use Committee and adhered to American Association for Laboratory Animal Care federal guidelines for the humane care and treatment of animals. Prehepatic PHT was produced by partial portal vein ligation, as described previously (5) . Briefly, a laparotomy was performed under ketamine HCl (25 mg/kg body wt i.v.) and 1% xylocaine local anesthesia. Under aseptic conditions the portal vein was isolated and a ligature was placed around the portal vein distal to the confluence of the right and left branches. A blunt 18-gauge needle was placed alongside the portal vein, the ligature was tightened around the needle and vein, and the needle was removed, producing a standard, calibrated stenosis. The abdomen was closed and the animal allowed to recover for 3 wk. Control animals were acclimated for 1 wk before the study.
Hemodynamic studies. Animals had their hemodynamics characterized, as previously described (5 (3) (4) (5) . There were no detectable differences observed between the hemodynamics of animals operated on the day of the experiment (NL), and the animals operated on 3 wk earlier (sham) (data not shown).
Preparation ofmembranes. Animals were killed with intravenous sodium phenobarbital. The superior mesenteric artery (SMA) was dissected to its tertiary branches, transected from the aorta, harvested, and placed in ice-cold buffer containing 10 mM Tris HCI and 1 mM EDTA (pH 7.5). The portal vein proximal to the ligature and to the tertiary branches of the superior mesenteric vein, and the small intestine were harvested and placed in buffer. Thoracic aorta and adrenals were also removed and placed in buffer. Adherent fat was removed by sharp dissection. Tissues were minced with a fine scissors and homogenized in a Tissumiser (Tekmar Ultra Turrax; Tekmar, Cincinnati, OH) for 10 s intervals. The homogenates were filtered through pre-wet nylon gauze and concentrated by centrifugation at 1,000 rpm for 10 min at 4VC. The supernatants were transferred and centrifuged at 30,000 g for 30 min at 4VC. The supernatants were discarded, and the pellets were resuspended in 10 mM Tris HCl containing 1 mM EDTA (pH 7.5), and washed at 30,000 g for 30 min at 4VC. The resulting pellet was resuspended in 50 mM Tris HCl (pH 7.4) containing 1 mM EDTA and stored at 70'C. Protein was measured by the method of Bradford ( 19) with BSA as a standard and subsequently used for determination ofAC activity, ADP-ribosylation, and immunoblotting.
Adenylyl cyclase activity. AC activity was determined by measuring Immunoblotting ofG-proteins. Membrane proteins were separated on 10% SDS-polyacrylamide, as described previously (21) . After SDS-PAGE, the separated proteins were electrophoretically transferred to nitrocellulose membranes (HYBOND-C; Amersham) using a Transphor electroblotter unit (Hoefer Scientific Instruments, San Francisco, CA) at 100 V for 3 h. After transfer, the membranes were incubated for 3 h in blocking solution containing 50 mM Tris base (pH 7.6), 4 mM MgCl2, and 14 mM NaCl Tris-buffered saline (TBS) supplemented with 30 mg/ml BSA, 0.1 % Tween-20, and 2 mg/ml sodium azide. (vol/vol) NP-40 and 5 min each in TBS alone before they were covered in cellophane and exposed to Kodak XAR-5 film with an intensifying screen at 70°C for 3-4 d. Equal protein loading was confirmed by Coomassie blue-staining of protein in each lane of the same blot. The signal intensity (integral volume) ofthe appropriate bands on the autoradiogram was analyzed using a personal densitometer (Molecular Dynamics, Sunnyvale, CA) and the Imagequant software package.
Statistics To determine whether the stimulatory actions of guanine nucleotides on AC activity were altered in PHT, the effects ofa nonhydrolyzable guanine nucleotide analogue, Gpp(NH)p, fluoride (NaF), and the diterpene derivative, forskolin, were examined in superior mesenteric artery, portal vein, thoracic aorta, and adrenal membranes from NL and PHT animals. As outlined in Table II , in the presence of GTP (100 gM), basal AC activity was decreased in membranes prepared from PHT superior mesenteric artery and thoracic aorta by 21±0.5 and 46±2.5%, respectively, compared with NL. Similarly, the response of AC activity to 10 gM Gpp(NH)p was reduced in both superior mesenteric artery and thoracic aorta membranes in PHT when compared with NL (Table II) . In the presence of GTP, the basal level of AC activity was higher in PHT portal vein membranes ( 178±60%). The ability ofGpp(NH)p, NaF, and forskolin to stimulate AC activity in PHT was significantly enhanced in portal vein membranes when compared with NL animals (810+248, 371±90, 732+267%, respectively) (Table   II ). In contrast, neither Gpp(NH)p-, NaF-, nor forskolin-stimulated levels of AC were significantly altered in adrenal membranes prepared from PHT animals. Further examination of AC activity in the absence of GTP revealed basal and stimu- All experiments were performed in the presence of GTP and results are the means±SEM of three separate experiments performed in triplicate.
The levels of adenylyl cyclase in PHT were statistically significant (* P < 0.05) compared with NL, as determined by ANOVA using Student's t test with corrections for multiple comparisons.
lated AC levels were similarly reduced in particulate fractions ofsuperior mesenteric artery and thoracic aorta in PHT (Fig. 1,  a and b) . To study whether the reduced AC activity in the superior mesenteric artery and thoracic aorta of PHT animals was due to defective G-protein-effector coupling, enzyme activity was studied in the presence of MnCl2. Manganese ions are known to uncouple the catalytic subunit of AC from guanine nucleotide regulatory sites (22) . Thus, under these conditions, the activity ofthe catalyst can be studied (Fig. 2) . In superior mesenteric artery and thoracic aorta membranes from PHT animals, AC activity was significantly lower in the presence of 5 mM MnCl2 (Fig. 2, a and b) in the absence or presence of forskolin, indicating the catalytic subunit of AC may be depressed in PHT superior mesenteric artery and thoracic aorta membranes. In the case ofthe portal vein membranes prepared from PHT animals, AC activity was elevated in the presence of 5 mM MnCl2. Moreover, in the absence/presence of forskolin and MnCl2 there was a significant increase in the AC activity in PHT portal vein (Fig. 2 c) . These results imply that basal and stimulated levels ofAC activity are impaired in the vasculature of PHT. Moreover, these changes in responsiveness to guanine nucleotide-, NaF-, and forskolin-stimulated cyclase activity are vessel specific and may involve changes in the catalytic subunit of AC.
Pertussis (Fig. 3 a) . The ribosylation increased over a range of 10-100 ug of membrane protein and was linear up to 60 ,ug (Fig. 3 b) . Therefore, a concentration of 20-30 ,ug (Fig. 4 a) .
Relative to the 40-kD pertussis toxin substrate levels in superior mesenteric artery and thoracic aorta membranes of 10 NL rabbits, the levels in 7 PHT animals were increased by 288±60
and 326+90%, respectively (P < 0.01) (Fig. 4 b) . No significant labeling was detected in the absence of pertussis toxin (Fig. 4 a) . In contrast to the PHT, superior mesenteric artery and thoracic aorta membranes, the amount of [32P]ADPribose incorporated by pertussis toxin was significantly reduced (69±7%, P < 0.01 ) in PHT portal vein membranes, compared with NL (Fig. 4, a and b) . There was no significant difference in the labeling of the 40 kD pertussis toxin substrate protein in adrenal membranes prepared from NL and PHT animals, respectively (Fig. 4, a and b) .
Immunoblotting of G-proteins. Since pertussis-toxin catalyzes the ribosylation ofseveral G-proteins (Gia 1, Gia2, Gia3, and Goa), it was ofinterest to identify the G-proteins that may be altered in PHT. therefore, the amount ofimmunodetectable G-protein levels were determined using specific antisera against Goa, Gsa, and different isoforms of Gia. The specific antibodies used were raised against GiaI /Gia2 (AS/7), Gia3/Goa (EC/2), and Gsa (RM/ 1). On Western blots prepared from particulate fractions ofnormal superior mesenteric artery, antiserum against Gia 1 /Gia2 (AS/7) recognized a major protein band with relative molecular weight of40,000 (Fig.  3) . The autoradiographic intensity of antibody binding to this protein band was linearly related to the total membrane protein applied to the gel ( 10-70 ,ug) on Western blots probed with AS/7 antiserum (Fig. 3) . Similar results were observed for thoracic aorta membranes using the AS/7 antibody (data not shown). Therefore, the antisera could be used to determine the relative concentrations ofimmunodetectable peptides in particulate fractions from NL and PHT superior mesenteric artery, portal vein, and adrenal and thoracic aorta membranes. As shown in Fig. 5 a, relative levels of the peptides detected by antiserum AS/7 (Gia 1 /Gia2) were significantly different in PHT thoracic aorta and portal vein membranes. In particular, the relative amounts of Gia 1 /Gia2 were significantly increased by 288±80%, P < 0.01 in PHT thoracic aorta membranes and decreased by 59±17%, P < 0.01 in PHT portal vein (Fig. 5, b) . The amount of immunodetectable Gia 1 /Gia2 in superior mesenteric artery and adrenal membranes was not significantly altered in NL versus PHT animals (Fig. 5 b) .
Using the antiserum against Gia3/Goa (EC/2), the amount of immunodetectable Gia3/Goa was significantly increased in PHT thoracic aorta membranes (1.58±0.13-fold, P < 0.01 increase compared with NL), and significantly reduced in the PHT portal vein fractions by 66±19% (P < 0.01 ) (Fig. 6,  a and b) . There was no significant difference in the amount of immunodetectable Gia3 /Goa peptides present on either supenor mesenteric artery or adrenal membranes prepared from PHT compared with NL animals (Fig. 6, a and b) .
To substantiate that these peptides were Gia1 /Gia2 species, we assessed whether they co-migrated with the pertussis toxin substrate in particulate fractions ofNL artery. Particulate fractions of normal superior mesenteric artery were ADP-ribosylated with [32P] NAD. Parallel samples were not treated with [32P]NAD. The reaction products were resolved by SDS/ PAGE. Electroblotting of the sample lanes that had not been ADP-ribosylated and subsequent probing with AS/7 antiserum demonstrated that the 32p labeled protein co-migrated with the relative molecular mass of 40 kD peptide recognized by the AS/7 antiserum (data not shown). Similar results were observed when these experiments were repeated with antibody EC/2 (data not shown). With the electrophoresis conditions adopted in these experiments, ADP-ribosylation did not substantially alter the electrophoretic migration of the Gia proteins. These results support the conclusion that the 40,000-mol wt peptide is a Gia protein.
Since changes in AC activity could result from altered levels of functional Gs a activity, we investigated the amount of Gs a in PHT membranes. Using specific antibodies against Gsa (RM/ 1), we determined the levels of Gsa proteins in membranes from NL and PHT animals. Fig. 7 , a and b, shows that the antiserum RM/ 1 clearly detected 42,000-and 44 kD forms of the stimulatory Gsa in NL and PHT particulate fractions from superior mesenteric artery, portal vein, thoracic aorta, and ADRs, respectively. The autoradiographic intensity of antibody binding to these protein bands was linearly related to the total membrane protein applied to the gel ( 10-70 ig) on Western blots probed with RM/1 antiserum (data not shown). However, there was no significant change from NL in the amount of immunodetectable Gsa present in PHT superior mesenteric artery, thoracic aorta, and adrenal membranes (Fig. 7) . In contrast, there was a significant reduction in the labeling of Gsa in portal vein membranes in PHT (21±7%, P < 0.05). To further corroborate this finding, we determined cholera toxin-dependent ADP-ribosylation of regulatory protein Gsa in superior mesenteric artery, portal vein, and thoracic aorta membranes from NL and PHT animals. The ribosylation assay was linear over a range of 10-100 ,ug of membrane protein (data not shown). Cholera toxin in the presence of [32P] NAD catalyzed the ADP-ribosylation of two protein bands of 42-and 44 kD in both NL and PHT animals. Moreover, the cholera toxin substrate co-migrated with the 42-and 44 kD peptides detected using the specific antisera (RM/ I) (data not shown). Labeling ofeither band was not significantly different in PHT superior mesenteric artery and thoracic aorta membranes from NL (Fig. 8, a and b) . In contrast, there was a significant reduction in the labeling of the cholera toxin substrates in PHT portal vein membranes, compared with NL membranes. These results suggest that the amount and functional activity ofGs a is not altered in PHT superior mesenteric artery and thoracic aorta, but is reduced in the portal vein of PHT rabbits. was significantly attenuated in PHT splanchnic and systemic arterial beds and potentiated in PHT portal vein. There is good evidence that the cAMP system mediates the vasodilatory responses to various hormones ( 18 ) . We concentrated our studies on G-proteins and their activity because G-proteins play an important role in the regulation of intracellular signal transa Pertussis toxin-ADP-ribsylation duction pathways, AC and phospholipase C, both of which regulate vascular tone ( 18) . A significant decrease in the stimulatory effects of Gpp(NH)p and forskolin on AC activity in superior mesenteric artery and thoracic aorta from PHT animals was demonstrated. The results ofboth the cholera toxin-catalyzed ADP-ri- Another explanation for the decreased sensitivity of AC to stimulation by forskolin in superior mesenteric artery and thoracic aorta from PHT animals may be a defective catalytic subunit of the enzyme itself or to altered expression of G-proteins, or both. Hence, the possibility of changes in the catalytic subunit ofthe cyclase enzyme was investigated by studying the effects of manganese ions on forskolin-stimulated AC activity in PHT. The data suggest that since the differences between PHT and NL animals were not attenuated in the presence of manganese, the catalytic subunit of the enzyme may be impaired. It seems therefore that there is a real change in the responsiveness of AC in PHT membranes that may be accounted for by an intrinsic change in the basal activity of the enzyme.
Activation of G-proteins by Gpp(NH)p allows for the expression ofboth the stimulatory and inhibitory G-protein pathways, and the amount ofAC stimulation is due to a net effect of both Gia and Gsa activity ( 13, 23) . Therefore, the decrease in basal AC activity and the decreased responsiveness to Gpp(NH)p in preparations derived from superior mesenteric artery and thoracic aorta of PHT animals could be due to an increase in inhibitory Gi protein activity. We have demonstrated that the levels of pertussis toxin substrate are significantly increased in particulate fractions from PHT superior mesenteric artery and thoracic aorta (Table III) . In contrast the enhanced stimulation of AC by Gpp(NH)p and forskolin in PHT portal vein membranes was associated with a marked decrease in pertussis toxin-mediated ADP-ribosylation (70%) of Gia despite a smaller 20% reduction in Gsa ribosylation by cholera toxin. These changes may account for the large increases in AC activity measured within this PHT vessel. No differences were observed in the amount of pertussis toxin-catalyzed labeling ofGia protein in adrenal membranes prepared from PHT animals.
Unfortunately, evaluating the functional activity of Gia proteins utilizing pertussis toxin-mediated ADP-ribosylation of Gi-protein substrates has several limitations. Namely (a) ADP-ribosylation measures only a subunit activity of a given G-protein ( 13) , (b) ADP-ribosylation is strongly dependent on the substrate quality of the Gia, (c) covalent modifications of the acceptor site for pertussis toxin (24, 25) , (d) phospholipid membrane environment of Gia ( 13, 24) and (e) endogenous ADP-ribosyltransferase (26) . A recent study by Taussig et al. (23) has shown that purified Gia subunits were capable of a concentration-dependent inhibition of AC and that myristoylation of Gia proteins was necessary for this inhibition. However, the sensitivity ofthe electrophoretic procedure adopted in the present study does not detect minor modifications in the peptide structure. Recent studies also suggest that the free 13-subunit of G-proteins rather than Gia mediates the inhibition of AC ( 13, 27) . Hence, the activity of the 1-subunit may be as important in the overall responsiveness ofthe AC system as the activity of Gia ( 13) . These data allow for the possibility Since altered pertussis toxin radiolabeling in membranes from PHT vessels may not reflect the absolute levels ofthe Gia proteins, we determined the amount of expressed Gia protein using specific antisera raised against Gial /Gia2 and Gia3/ Goa. We demonstrated enhanced levels of Gial /Gia2 and Gia3/Goa in PHT thoracic aorta preparations and reduced levels ofthese peptides in portal vein from PHT animals. However, the levels of Gia peptides in the superior mesenteric artery and adrenals of PHT were unaltered (Table III) . In the thoracic aorta and portal vein, the close correlation between altered functional activity of Gia proteins in PHT animals, as determined by (a) pertussis toxin-catalyzed ADP-ribosylation and (b) the amounts ofimmunoreactive Gia in the same preparations suggests that these changes may be responsible for the differential responsiveness of PHT membranes to stimulation of AC by guanine nucleotides and forskolin (Table III) . However, this is not the case with respect to the PHT superior mesenteric artery membranes, where the increased functional activity of Gia is not associated with changes in the levels of immunodetectable Gia (Table III) .
The etiology of the discordance between immunodetectable levels of Gia-proteins in the superior mesenteric artery of PHT and measurements of AC activity and levels of pertussis toxin substrate are not obvious. A covalent modification could augment Gia function in PHT, or alternatively, the modification might normally reduce Gia function in NL animals. In any case, a covalent modification could allow for a more complete ADP-ribosylation by pertussis toxin in PHT membranes. Several covalent modifications of G-proteins that alter Gia bioactivity have been described (23, 28, 29) . The reason for the selective changes within these blood vessels may also be related to the enhanced level of vasoactive substances locally released within the mesentery after acute portal vein ligation. We and others have shown significant increases in the local production of prostacyclin, nitric oxide, and glucagon, which may acutely modulate the signal transducing pathways in PHT superior mesenteric artery but not systemically (2, 4, 7, 9, 10, 30) . For example, previous studies have demonstrated portal venous prostacyclin activity exceeded peripheral venous activity twoto threefold in PHT (30) . Moreover previous studies have shown that increased splanchnic and portal venous vasodilator substances (i.e., glucagon, prostacyclin, and bile acids) and reduced vascular responsiveness of the superior mesenteric artery to exogenous vasoconstrictors (i.e., angiotensin-II, norepinephrine, and vasopressin) both contribute to the intestinal vasodilation associated with chronic PHT, independent of variations in systemic cardiovascular homeostasis (11). It is possible therefore that changes in the responsiveness of vasoconstrictor hormones occur selectively in some vascular beds and are absent in others due to regional elevated levels of endogenous vasodilators and their subsequent modification of the signalling transducing pathways within a specific vascular bed.
Up-regulation of Gi/Go proteins may play a central role in the long-term adaptation of the arterial systemic and splanchnic vascular beds to chronic activation of AC by endogenous vasodilators (glucagon and prostacyclin). Accordingly, chronic stimulation of the f3-adrenoreceptor AC pathway resulted in up-regulation of Gia protein levels (31) . Chronic pathological states, such as human heart failure, are associated with increased functional activity of Gia ( 13) . It may be that the up-regulation of Gia/Goa protein levels and pertussis toxin-sensitive G-proteins in the superior mesenteric artery and thoracic aorta from PHT animals are chronic regulatory events initiated by high circulating levels of endogenous vasodilators. Increases in Gia proteins may not only contribute to the desensitization of stimulatory AC pathways (32) , but also may lead to sensitization (hyperactivity) ofinhibitory adenylyl cyclase and phospholipase C pathways (31, 32) .
The results of the present study have been obtained in a model of prehepatic PHT. The finding that different humoral factors are important in the pathogenesis of PHT is now well established and increased levels of endogenous vasodilators (PGI2 and glucagon) have been reported in prehepatic and cirrhotic models of PHT (4, 5, 7) . Previous studies have suggested isolated superior mesenteric vein, and portal vein from PHT rats, were less sensitive to the vasoconstrictive effects of norepinephrine (33) (34) (35) . Although the specific vascular receptors were not determined in this present study, it is conceivable that the dramatic decrease in the amount and functional activity of Gia in portal vein of PHT, despite a smaller reduction in the amount and functional activity of Gsa, may modulate signal transduction to several intracellular pathways, leading to an overall reduced splanchnic sensitivity to vasoconstrictive stimulation (34, 35) . Alternatively, these changes in G-protein levels and function may be associated with the marked vascular smooth muscle hypertrophy after partial ligation of the portal vein in this model of prehepatic PHT (35) . Various studies of the portal vein in experimental PHT have revealed a dramatic structural response of the smooth muscle and profound functional adjustments with respect to contractile force and responsiveness to catecholamines (35) .
In summary, we have demonstrated that the expression of Gia regulatory proteins are altered in PHT. Chronic liver disease has been known for many years to be associated with changes in the splanchnic and systemic circulation (1). Similar changes have been reported in experimental prehepatic models of PHT ( 1 ) . The current studies define for the first time altered levels of guanine-nucleotide regulatory proteins in the vasculature of PHT animals. Further studies are necessary to determine if these changes in G-protein function are part of, the cause of, or a consequence of the hyperdynamic vasculopathy of PHT.
